This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Bristol-Myers Squibb Compnay, Pfizer Corporation. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,745 
1 out of 4,489 
Years Active: 2024
Title: The Innovations of Brett Waybrant
Introduction
Brett Waybrant is an accomplished inventor based in Bend, Oregon. He has made significant contributions to the field of pharmaceuticals, particularly with his work on apixaban formulations. His innovative approach has led to advancements in the treatment of thromboembolic disorders.
Latest Patents
Brett Waybrant holds a patent for an apixaban pharmaceutical formulation. This formulation is designed to enhance the treatment of thromboembolic disorders, showcasing his commitment to improving patient outcomes through innovative solutions. He has 1 patent to his name, reflecting his expertise and dedication to the field.
Career Highlights
Throughout his career, Brett has worked with prominent companies such as Bristol-Myers Squibb Company and Pfizer Corporation. His experience in these leading pharmaceutical firms has equipped him with the knowledge and skills necessary to develop groundbreaking formulations.
Collaborations
Brett has collaborated with notable professionals in the industry, including Sherif Ibrahim Farag Badawy and Timothy D. Stevens. These partnerships have further enriched his work and contributed to the success of his innovations.
Conclusion
Brett Waybrant's contributions to pharmaceutical formulations, particularly in the area of apixaban, highlight his role as a significant inventor in the field. His work continues to impact the treatment of thromboembolic disorders, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile